Abstract
The prodrug pyrazinamide (PZA) is metabolized by the mycobacteria to pyrazinoic acid (POA), which is expelled into the extracellular environment. PZA resistance is highly associated to a lack of POA efflux. Thus, by detecting a reduction of the concentration of POA in the extracellular environment, by means of lab-on-a-chip (LoC)-SERS (surface-enhanced Raman spectroscopy), an alternative approach for the discrimination of PZA resistant mycobacteria is introduced. A droplet-based microfluidic SERS device has been employed to illustrate the potential of the LoC-SERS method for the discrimination of PZA resistant mycobacteria. The two analytes were detected discretely in aqueous solution with a limit of detection of 27 μm for PZA and 21 μm for POA. The simultaneous detection of PZA and POA in aqueous mixtures could be realized within a concentration range from 20 μm to 50 μm for PZA and from 50 μm to 80 μm for POA.
Original language | English (US) |
---|---|
Article number | 511 |
Journal | Applied Sciences (Switzerland) |
Volume | 9 |
Issue number | 12 |
DOIs | |
State | Published - Jun 1 2019 |
Externally published | Yes |
Keywords
- Drug resistant mycobacteria
- Lab-on-a-Chip (LoC)
- Personal medicine
- Quantitative SERS detection of PZA and POA
- Surface-enhanced Raman spectroscopy (SERS)
ASJC Scopus subject areas
- General Materials Science
- Instrumentation
- General Engineering
- Process Chemistry and Technology
- Computer Science Applications
- Fluid Flow and Transfer Processes